Commonwealth Bank of Australia (CMWAY)

Verve Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 31, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Market Capitalization	191,987	142,113	111,765	105,862	132,707	84,806
Market Cap Growth	24.30%	27.15%	5.58%	-20.23%	56.48%	-17.36%
Last Close Price	113.49	81.88	62.19	55.38	64.53	40.16
PE Ratio	31.76	22.67	16.80	14.37	17.39	12.81
PS Ratio	11.60	8.15	6.38	6.11	7.48	5.74
PB Ratio	4.12	2.91	2.34	2.11	2.25	1.71
Debt / Equity Ratio	4.20	3.72	4.10	4.08	3.18	3.31
Return on Equity (ROE)	13.21%	13.10%	13.98%	12.66%	11.74%	10.44%
Return on Assets (ROA)	0.76%	0.76%	0.82%	0.83%	0.84%	0.74%
Earnings Yield	3.15%	4.41%	5.95%	6.96%	5.75%	7.81%
FCF Yield	-11.74%	-22.80%	-28.26%	-36.92%	-11.36%	-26.76%
Dividend Yield	2.73%	3.79%	4.82%	4.79%	4.07%	5.12%
Payout Ratio	79.68%	81.15%	71.18%	61.13%	40.59%	79.53%
Buyback Yield / Dilution	3.44%	0.89%	1.80%	5.22%	-2.06%	0.10%
Total Shareholder Return	6.17%	4.68%	6.62%	10.01%	2.01%	5.23%

Source: S&P Global Market Intelligence. Banks template. Financial Sources.